Press Releases
June 30, 2022
IN8bio to Present at July Investor and Scientific Conferences
June 8, 2022
IN8bio Announces Presentation at Jefferies Global Healthcare Conference and Additional June Investor and Scientific Conferences
June 6, 2022
IN8bio Announces Positive Glioblastoma Multiforme (GBM) Clinical Updates from the INB-200 Phase 1 Trial Presented at ASCO 2022
May 17, 2022
IN8bio Announces Data Emerging from its Recently Unveiled Gamma-Delta T cell “Off-the-Shelf” Induced Pluripotent Stem Cell Platform
May 12, 2022
IN8bio Reports First Quarter 2022 Financial Results and Provides Corporate Update